218 related articles for article (PubMed ID: 32425503)
1. Boston Type 1 Keratoprosthesis: Updated Perspectives.
Nonpassopon M; Niparugs M; Cortina MS
Clin Ophthalmol; 2020; 14():1189-1200. PubMed ID: 32425503
[TBL] [Abstract][Full Text] [Related]
2. The treatment of end-stage corneal disease: penetrating keratoplasty compared with Boston type 1 keratoprosthesis.
Bonneau S; Tong CM; Yang Y; Harissi-Dagher M
Graefes Arch Clin Exp Ophthalmol; 2022 Sep; 260(9):2781-2790. PubMed ID: 35384455
[TBL] [Abstract][Full Text] [Related]
3. The Boston keratoprosthesis.
Saeed HN; Shanbhag S; Chodosh J
Curr Opin Ophthalmol; 2017 Jul; 28(4):390-396. PubMed ID: 28383302
[TBL] [Abstract][Full Text] [Related]
4. Boston type I keratoprosthesis: Review.
Magalhães FP; Sousa LB; Oliveira LA
Arq Bras Oftalmol; 2012; 75(3):218-22. PubMed ID: 22872210
[TBL] [Abstract][Full Text] [Related]
5. Boston type 1 keratoprosthesis outcomes in ocular burns.
Magalhães FP; Hirai FE; de Sousa LB; de Oliveira LA
Acta Ophthalmol; 2013 Sep; 91(6):e432-6. PubMed ID: 23406295
[TBL] [Abstract][Full Text] [Related]
6. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
Aldave AJ; Kamal KM; Vo RC; Yu F
Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Results of the Boston Keratoprosthesis for Unilateral Corneal Disease.
Kosker M; Suri K; Rapuano CJ; Ayres BD; Nagra PK; Raber IM; Hammersmith KM
Cornea; 2015 Sep; 34(9):1057-62. PubMed ID: 26114818
[TBL] [Abstract][Full Text] [Related]
8. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
Sejpal K; Yu F; Aldave AJ
Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
[TBL] [Abstract][Full Text] [Related]
9. [Boston keratoprosthesis type 1].
Harissi-Dagher M; Slim E
J Fr Ophtalmol; 2019 Mar; 42(3):295-302. PubMed ID: 30857801
[TBL] [Abstract][Full Text] [Related]
10. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.
Kang JJ; de la Cruz J; Cortina MS
Cornea; 2012 Dec; 31(12):1436-40. PubMed ID: 22367042
[TBL] [Abstract][Full Text] [Related]
11. Boston keratoprosthesis type 1 for limbal stem cell deficiency after severe chemical corneal injury: A systematic review.
Shanbhag SS; Saeed HN; Paschalis EI; Chodosh J
Ocul Surf; 2018 Jul; 16(3):272-281. PubMed ID: 29597010
[TBL] [Abstract][Full Text] [Related]
12. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
Greiner MA; Li JY; Mannis MJ
Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
[TBL] [Abstract][Full Text] [Related]
13. [The Boston keratoprosthesis in the management of corneal blindness: Indications and limitations].
Stolowy N; Callet M; Beylerian M; Hoffart L; Yin GHW
J Fr Ophtalmol; 2018 Sep; 41(7):642-649. PubMed ID: 30170706
[TBL] [Abstract][Full Text] [Related]
14. Boston type 1 keratoprosthesis: the university of california davis experience.
Bradley JC; Hernandez EG; Schwab IR; Mannis MJ
Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
[TBL] [Abstract][Full Text] [Related]
15. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.
Lee R; Khoueir Z; Tsikata E; Chodosh J; Dohlman CH; Chen TC
Ophthalmology; 2017 Jan; 124(1):27-35. PubMed ID: 27538795
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency.
Aravena C; Bozkurt TK; Yu F; Aldave AJ
Cornea; 2016 Sep; 35(9):1156-64. PubMed ID: 27387566
[TBL] [Abstract][Full Text] [Related]
17. Boston Type 1 Keratoprosthesis for Gelatinous Drop-Like Corneal Dystrophy.
Lekhanont K; Jongkhajornpong P; Chuephanich P; Inatomi T; Kinoshita S
Optom Vis Sci; 2016 Jun; 93(6):640-6. PubMed ID: 26990741
[TBL] [Abstract][Full Text] [Related]
18. Results from the multicenter Boston Type 1 Keratoprosthesis Study.
Zerbe BL; Belin MW; Ciolino JB;
Ophthalmology; 2006 Oct; 113(10):1779.e1-7. PubMed ID: 16872678
[TBL] [Abstract][Full Text] [Related]
19. Boston keratoprosthesis type I in the elderly.
Homayounfar G; Grassi CM; Al-Moujahed A; Colby KA; Dohlman CH; Chodosh J
Br J Ophthalmol; 2017 Apr; 101(4):514-518. PubMed ID: 27381593
[TBL] [Abstract][Full Text] [Related]
20. The Aurolab Keratoprosthesis (KPro) versus the Boston Type I Kpro: 5-year Clinical Outcomes in 134 Cases of Bilateral Corneal Blindness.
Basu S; Serna-Ojeda JC; Senthil S; Pappuru RR; Bagga B; Sangwan V
Am J Ophthalmol; 2019 Sep; 205():175-183. PubMed ID: 30905723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
